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Abstract Intra-operative frozen section analysis (FS anal-
ysis) of sentinel lymph nodes (SLNs) in patients with breast
cancer can prevent a second operation for axillary lymph
node dissection. In contrast, loss of tissue during FS
analysis may impair the probability to detect lymph node
metastases. To determine the effect of tissue loss on the
probability of detection of metastases, dimensions and
tissue loss resulting from intra-operative frozen section
analysis were measured for 21 SLNs. In a mathematical
model, the influence of tissue loss on the probability to
detect metastases was calculated in relation to SLN size for
various pathology protocols: an American, a widely used
European, the extensive ‘Milan’ and the Dutch protocol.
For median-sized SLN 11×8×5 mm (length×width×
height), FS analysis led to a median loss of 680 μm
(13.6%) of the height of the SLN. Irrespective of SLN size
or used pathology protocol, the probability of detecting
2 mm metastases remained unchanged or even increased
(0–12.8%). Moreover, the probability to detect 0.2 mm
metastases increased for the majority of tested combina-
tions of SLN size, tissue loss and used protocol. Only when
combining maximum tissue loss and smallest SLN size in
the Dutch protocol, or when applying the extensive Milan
protocol on a median-sized SLN, the probability to detect
0.2 mm metastases decreased by 2.7% and 14.3%,
respectively. Contrary to ‘common knowledge’, doing FS
analysis of SLNs does not impair the probability to detect
lymph node metastases.
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Introduction
Sentinel lymph node (SLN) biopsy has proven to be an
accurate staging procedure in breast cancer patients and has
replaced axillary lymph node dissection (ALND) in
clinically ‘node negative’ axillas [1]. Though the SLN
procedure has led to a more thorough inspection of these
lymph nodes in general, their specific examination varies
substantially throughout Europe [2] and the USA [3].
Intra-operative frozen section (FS) analysis of an SLN
enables ALND to be performed during the same operation
if tumour metastases are detected. When an SLN is
prepared for FS analysis, part of the lymph node is
sacrificed to obtain a reliable cut from the SLN for
pathological examination. This loss of tissue may influence
the probability to detect small lymph node metastases. As
such, it may be a reason to discourage the use of FS
analysis [4–6].
In the present study, the loss of SLN tissue during FS
analysis is measured and the effect of the tissue loss on the
probability to detect metastases within an SLN for four
different, commonly used protocols is calculated.
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Intra-operative FS analysis and definitive pathology
examination of SLNs (applying the Dutch guideline
for evaluating SLNs)
In our hospital since 2000, intra-operative FS analysis of
SLNs is routinely performed in breast cancer patients.
Following retrieval of axillary SLNs, lymph nodes are
transported to the pathology department and processed by
the pathologist. After clearing the node from surrounding
fat, SLNs are bisected along their longest axis. The two
emerging halves are then frozen in Tissue-tek (Klinipath,
Duiven, The Netherlands) after which preparatory cuts are
taken from the centre of the nodes at variable intervals until
appropriately examinable cuts are obtained from both
halves. Appropriate cuts are slices that comprise an
(almost) complete cross section from the lymph node.
These intra-operative cuts are stained with haematoxylin–
eosin (HE) and are examined by the pathologist for the
presence of metastases. The remaining tissue is subsequently
formalin-fixedandexaminedaccordingtotheDutchguideline
for evaluating SLNs, i.e. taking three cuts from either half
starting from the centre with 250 μm distance between
t w oc u t s .S L N st h i c k e rt h a n1 0m ma r es e c t i o n e di n t o
2-mm slices. According to the protocols, samples are
s t a i n e db o t hw i t hH Ea n di m m unohistochemically with
antibodies to cytokeratin [7].
The study was approved by the institutional ethics
committee. The size of SLNs was measured and tissue loss
during the FS procedure was assessed. For a range of SLN
sizes, the influence of the varying amount of tissue loss on
the probability to detect metastases was calculated in a
mathematical model, representing the processing of SLNs
according to the Dutch pathology protocol. Subsequently,
the influence of applying existing, alternative examination
protocols was determined.
Establishing the size of an SLN
The dimensions of 21 SLNs obtained during breast surgery
of ten consecutive female patients with cT1-2N0 breast
cancer were measured by a pathologist after clearance of
surrounding fat and before fixation. Length, height and
width of the SLN were measured in millimetres (mm). In
order to estimate the volume of an SLN, a triaxial, ellipsoid
shape is assumed with parameters (half-lengths) ax (width),
ay (depth) and b (height) (Appendix A; Fig. 4)
Tissue loss associated with frozen section analysis
For intra-operative FS analysis, an SLN is first bisected
along its longest axis. FS are prepared from the cut surface
(centre part) and preparatory FS are cut until a first section
can be obtained that contains a complete cross section from
the SLN (Fig. 1). Tissue loss was estimated by counting the
number of preparatory sections cut on a cryostat (Leica
CM1850) multiplied by the section thickness.
Calculating the influence of tissue loss on the probability
of detecting metastases in the SLN
The Dutch guideline for evaluating SLNs advocates to
bisect SLNs and to take three cuts from both halves starting
from the centre with 250 μm distance between two cuts (or
cuts at 2-mm intervals when an SLN is thicker than
10 mm). In a previous study [8], a model was presented to
calculate the probability of detecting metastases in an SLN.
This probability can be interpreted as the complementary risk
of missing metastases that remain unnoticed due to their
locationinthe outerareas ofthe SLNsorinthe tissuebetween
the cuts.
In the present study, we adopt and adapt this model to
assess the probability of detecting the smallest (0.2 mm) and
the largest (2 mm) single micrometastasis (TNM-N-class
pN1mi) when performing FS analysis. The metastasis is
represented as a ball shape with diameter m. Ac i r c u l a rs h a p e
of a micrometastasis and a random location of the micro-
metastasis within the SLN are assumed (Appendix A;
Fig. 4). The probability of detecting a metastasis in a
particular tissue is roughly determined as the ratio of the
volume covered by the histological examination and the total
volume of the tissue (V). The pathology protocols, described
below, all divide the unfixed tissue into two halves, after
which a number of cuts n with height c and a distance d are
taken from either half. The number of cuts depends on the
protocol and the size of the SLN. If a metastasis with size m
is present in the tissue and intersects with the examined
section, it is assumed to be discovered with certainty. For
preparing intra-operative FS, the two halves are levelled, cut
Fig. 1 Graphical presentation of bisecting an SLN, wasting tissue (black) by cutting preparative sections for FS analysis and further examination
of the SLN. SLN sentinel lymph node
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both halves (Fig. 1). Thus, the potential waste is taken from
the middle segment of the lymph node. The wasted tissue is
assumed to have a total height w, of which wL concerns the
lower half, and wU the upper half of the tissue. The choice of
which half of the tissue is the lower or upper part is
immaterial; the distinction between different amounts of
waste from both halves merely adds flexibility to the model.
Conceptually, wasting tissue has two opposite effects on the
probability of detecting metastases during FS examination.
On the one hand, the wasting tissue might cause the
pathologist to miss metastases which reduces the probability
of detection (the pure waste effect). On the other hand,
levelling of the tissue halves has the effect of covering more
of the periphery of the lymph node, which may actually
increase the probability of detection (the advancement
effect). The precise consequences of wasted tissue for the
detection probability will depend on the pathology protocol,
the size of the metastasis, the wasted volume and the size of
the SLN. The specifics of the mathematical model are
summarised in Appendix A.
The effect of FS analysis when alternative pathology
protocols for the examination of SLNs followed
The effect of FS analysis has been studied for three
commonly used protocols in addition to the Dutch protocol:
the American pathology guideline [4], the ‘Milan’ protocol
as described by Veronesi [1] and the protocol described by
Cserni [2] as the most commonly used practice in Europe.
While the Dutch protocol takes three cuts from either half
o ft h et i s s u ea tad i s t a n c eo fd=250 μm, American
guidelines suggest sectioning SLNs at 2-mm intervals after
bisecting the SLN. The protocol described by Cserni as the
most commonly used in Europe takes six cuts from both
halves at a distance of d=150 μm. The most extensive
Milan protocol takes 15 cuts from both halves at a distance
of d=50 μm, after which the remaining tissue is cut at
100 μm. The vertical size of the cuts is c=5 μm for all
protocols except the Milan protocol in which c=4 μm. The
specifics of these protocols are graphically represented in
Fig. 2. The effect of FS analysis on the probability of
detection has been assessed for various combinations of the
Milano Protocol
VS Protocol (minimum advise)
Dutch Protocol
Europe Protocol
Fig. 2 Graphical presentation
of the various pathology
protocols
Table 1 Probability to detect 0.2-mm metastases in SLNs without and with frozen section analysis
Small SLN Median SLN Large SLN
7×6×4 mm 11×8×5 mm 20×10×10 mm
Without FS With FS Without FS With FS Without FS With FS
Minimum amount of lost tissue during FS (72 μm) 44.0% 46.7% 35.8% 38.1% 18.3% 19.5%
Median amount of lost tissue during FS (680 μm) 44.0% 47.4% 35.8% 39.8% 18.3% 21.2%
Maximum amount of lost tissue during FS (1,250 μm) 44.0% 41.3% 35.8% 36.7% 18.3% 20.8%
Probability values were calculated for the various combinations of minimum, median and maximum tissue loss and minimum, median and
maximum SLN size
SLN sentinel lymph node, FS frozen section
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tissue corresponding with the different pathology protocols.
Results
The median size of the 21 examined SLNs was 11×8×5 mm
(range7×6×4–20×10×10mm;length×width×height).After
bisecting the SLN, cutting preparatory sections from the
centre of the SLN led to a median loss in the height of
tissue of 680 μm( r a n g e7 2 –1,250 μm). This tissue loss
comprised 13.6% (range 1.4–25%) of the height of a
median SLN.
In Table 1, the probabilitytodetectmetastaticinvolvement
inSLNsofdifferentsizesaswellastheinfluenceofFSrelated
tissue loss is shown for 0.2-mm metastases when SLNs are
processed according to the Dutch pathology protocol. The
probability to detect 0.2-mm metastases only decreased when
the maximum amount of tissue was wasted when examining
the smallest SLN. In that case, the probability to detect
a 0.2-mm metastasis decreased from 44.0% to 41.3%. For all
other combinations, the probability of detection increased
when doing FS analysis, the increase of thischance to detect a
0.2-mm metastasis ranging between 0.9% and 4.0%.
The probabilities of detecting 2.0-mm metastases are
shown in Table 2. For small- and median-sized SLNs, the
probability of detection remained 100%, irrespective of doing
FS analysis. For large SLNs, in which the probability of
detection of 2.0-mm metastasis without FS analysis is 69.1%,
the use of FS analysis increased the probability of detection,
and the increase of the detection probability varied between
0.9% and 12.8%.
The effect of FS analysis is graphically represented in
Fig. 3. When applying the Dutch guideline for the
pathology examination of SLNs, the loss of tissue from
the centre of the SLN resulted in an advancement of the
examined area towards the outer areas of the SLN, on
average leading to a higher probability to detect metastases.
In Table 3, the effect of tissue loss resulting from FS
analysis is summarised for the alternative pathology
protocols, i.e. the Milan, the European and the American
protocol. For 0.2-mm metastases, the probability of
detection increased for the European and American protocol,
from 55.8% to 57.7% and from 12.3 to 18.1% respectively.
Only in the extensive Milan protocol, a 14.3% decrease to
detect 0.2-mm metastases was observed when doing FS
analysis. The probability of detecting 2.0-mm metastases
remainedthesamefortheEuropeanand the Milan protocol,
i.e. 100%, and it increased when applying the American
protocol from 94.5% to 99.5%.
Table 2 Probability to detect 2-mm metastases in SLNs without and with frozen section analysis
Small SLN Median SLN Large SLN
7×6×4 mm 11×8×5 mm 20×10×10 mm
Without FS With FS Without FS With FS Without FS With FS
Minimum amount of lost tissue during FS (72 μm) 100% 100% 100% 100% 69.1% 70.0%
Median amount of lost tissue during FS (680 μm) 100% 100% 100% 100% 69.1% 76.4%
Maximum amount of lost tissue during FS (1,250 μm) 100% 100% 100% 100% 69.1% 81.9%
Probability values were calculated for the various combinations of minimum, median and maximum tissue loss and minimum, median and
maximum SLN size
SLN sentinel lymph node, FS frozen section
Fig. 3 Graphical presentation of the effect of tissue loss from the
centre of the SLN: advancement of examined tissue towards the outer
area. SLN sentinel lymph node
Table 3 Effect of frozen section on detection probabilities when
applying alternative pathology protocols for SLN examination
Metastasis size Without FS With FS
European protocol 0.2 mm 55.8% 57.7%
2 mm 100% 100%
Milan protocol 0.2 mm 100% 85.7%
2 mm 100% 100%
Dutch protocol 0.2 mm 35.8% 39.8%
2 mm 100% 100%
American protocol 0.2 mm 12.3% 18.1%
2 mm 94.5% 99.5%
SLN sentinel lymph node, FS frozen section
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In the present study, a beneficial effect of FS analysis on the
probability to detect micrometastases in SLNs is observed.
Despite losing approximately 14% of tissue from the centre
of the SLN, the probability to detect the smallest micro-
metastasis in an SLN of median size with median tissue
loss increased by 4%, while the probability to detect the
smallest macrometastasis remained unchanged (100%) for
the Dutch pathology protocol. Variations in the probability
of detection depend on the size of the SLN and the amount
of wasted tissue. These paradoxical findings were con-
firmed for most of the other pathology protocols.
According to our knowledge, no studies have been
performed that actually measure the potentially adverse effect
of tissue loss resulting from FS analysis. However, various
authorshavehypothesiseda substantialeffectoflosttissuedue
to FS analysis [5, 6]. Based on this assumption, ‘conventional
wisdom’ has been ground for dissuasion of this intra-
operative technique. In addition, this presumed effect is the
main reason to advocate other intra-operative techniques such
as touch imprint cytology or intra-operatively assessing
greater volumes of SLNs or even whole lymph nodes without
losing tissue by one-step nucleic acid amplification [9, 10].
The observed paradoxically increased probability to
detect small lymph node metastases when doing FS
analysis can be explained in a number of ways. Firstly,
the median loss of tissue due to FS analysis was 680 μm.
Serial sectioning is in itself accompanied by a risk of
‘missing’ metastases that are smaller than the interval
between the cuts (250 μm according to the Dutch guide-
lines). Conceptually, the observed loss of 680 μm may be
viewed as an extension of the cut interval by 430 μm (680
instead of 250 μm). Furthermore, if a metastasis is larger
than the height of wasted tissue, the probability to detect
such a metastasis remains unaffected. Finally, losing tissue
from the centre of the node leads to an advancement of the
sections to be analysed microscopically towards the outer
areas of the SLN. So, the loss of 430 μm from the centre of
the node is accompanied by examining 680 μm deeper into
the periphery of an SLN. This ‘advancement’ effect
increases the probability to detect metastases in case of
pathology protocols that advocate examining the central
part of the lymph node. This effect is absent in case of
protocols advocating extensive serial sectioning of the
entire SLN, e.g. the Milan protocol.
Thus, preparing SLNs during FS analysis and thereby
sacrificing tissue will initially have a favourable effect on
the probability to detect metastases but, with on-going loss,
will eventually result in a decreased probability. Differences
in applied protocols and the absence of consensus regarding
a minimum metastasis size that should be detected under all
circumstances preclude formulating a rule of thumb that can
be used to suggest what proportion of an SLN can be
sacrificed during FS analysis without compromising the
detection probability. Then again, the results of the present
study demonstrate that the wasted tissue never compro-
mised the chance to detect lymph node metastases when
commonly used protocols are applied.
Only when using the protocol as described by Veronese et
al. [1], which implies cutting the entire SLN at 50-μm
intervals, the probability to detect 0.2 mm was decreased by
14.3% (from 100% to 85.7%) while the chance to detect the
smallest macrometastasis was unimpaired. Then again, few
other institutions advocate such an extensive examination of
SLNs. In this respect, it is noteworthy that the probability to
detect a 0.2-mm metastasis was very limited in all protocols
except for the Milan protocol, as demonstrated in a previous
study [8]. Given the ongoing discussion regarding the
prognostic effect of micrometastases and isolated tumour
cells [11, 12] ,t h i sm a yb ear e a s o nt oc o n s i d e ram o r e
extensive protocol.
The present study has a number of limitations. In designing
the model, a number of assumptions were adopted such as the
ellipsoid shape of an SLN, the circular-shaped metastasis, as
well as the random position of the metastasis within an SLN.
Furthermore,weassumedthatsubsequentdefinitivepathology
examination was not associated with tissue loss irrespective of
the use of FS analysis, whereas in reality, tissue loss
accompanies the final pathological examination too. Further-
more, in this model, a lymph node metastasis is assumed to be
single, whereas the probability of detecting metastases
increases with the number of metastases in the SLN. As a rule
of thumb, the probability to detect at least one of multiple
metastases will increase for all examination protocols, and the
effect of FS analysis will never lead to an increased risk of
missing metastases.
In summary, contrary to our expectation as well as
‘common knowledge’, FS analysis of sentinel lymph nodes
by bisecting lymph nodes, wasting of preparative sections
from the centre does not impair the probability to detect
lymph node metastases.
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This appendix presents the mathematical model to deter-
mine the probability of detecting micrometastases in an
SLN with and without frozen section analysis. The
pathological protocols considered in the present paper all
divide the raw tissue into two halves. From each half, one
frozen section with height fc and n cuts with height c are
taken at inter-cut distance d; if no frozen section analysis is
applied, then the height of the frozen section is simply
equal to zero, fc=0. The number of cuts depends on the
protocol and the size of the tissue. If a metastasis with size
m is present in the tissue and intersects with the inspected
cuts, it is assumed to be detected with certainty. During the
preparation of the cutting process, the two halves are
levelled to ensure that the first cut covers the full surface of
the remaining half. The implied waste is taken from the
midst of the original tissue. It is assumed to have a total
height w, of which wL concerns the lower half, and wU the
upper half of the tissue. The choice of which half of the
tissue is the lower or upper part is immaterial; the
distinction between different amounts of waste from both
halves merely adds flexibility to the model. The occurrence
of pathological waste has two opposite effects on the
probability of detecting metastases. On the one hand, waste
may lead the pathologists to definitively miss a metastasis,
which reduces the probability of detection (the pure waste
effect). On the other hand, levelling of the tissue halves
causes the volume covered by the pathological inspection to
include more of the outer parts of the tissue, which may
actually increase the probability of detection (the advance-
ment effect). The precise consequences on the detection
probability of wasted tissue will depend on the size of the
metastasis, the wasted volume and the total volume of the
tissue.
General assumptions
We model a given tissue by means of a triaxial ellipsoid
with parameters (half-lengths): ax (width), ay (depth) and b
(height); ax≥ay≥b>0. The volume of the entire ellipsoid is
obtained as V=4π ax ay b/3, while the volume of an
arbitrary (horizontal) slice from this ellipsoid between
points z0 and z1, –b≤z0≤z1≤b, can be derived as:
Iðz0;z1Þ¼paxay z1   z0 ðÞ  
1
3b2 z3
1   z3
0
     
ð1Þ
Obviously, V=I(−b, b). The probability p of detecting a
metastasis, if it is present, is defined as the total tissue
volume covered by the pathological inspection (VPI)
corrected for waste (UW) and unobserved volume due to
metastases smaller than the inter-cut distance (Um<d)
divided by the tissue volume (V):
p ¼
VPI   UW   Um<d
V
ð2Þ
Further formalisation will distinguish between situations
without and with pathological waste.
Fig. 4 The model to determine
the probability of detecting
micrometastases in SLN with
and without frozen section
analysis
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In the absence of waste, assuming frozen section and
symmetric halves, the total tissue volume covered by the
pathological inspection is equal to:
VPI ¼ I½ ðfc þ c þð n   1Þðc þ dÞþmÞ;
fc þ c þð n   1Þðc þ dÞþm 
ð3Þ
with n the number of cuts. The volume unseen due to waste
is obviously void, UW=0. Metastases with size equal or
larger than the inter-cut space (m≥d)w i l la l w a y sb e
detected, if they are within this inspected volume (Um<d=0).
Smaller metastases (m<d) within the inspected volume may
be missed when they lie between two cuts without
intersecting them. Considering cuts j and j+1, j=1, …, n-1,
the inter-cut volume unobserved by the pathologist can be
approximated as the average of If cþ c þ j   1 ðÞ c þ d ðÞ ; ½
fc þ jcþ d ðÞ   m  and If cþ c þ j   1 ðÞ c þ d ðÞ þ m; ½
fc þ jcþ d ðÞ   . Alternatively, one could approximate this
unseen volume by If cþ c þ j   1 ðÞ c þ d ðÞ þ m=2; ½
fc þ jcþ d ðÞ   m=2Þ, but the difference between the two
approaches is marginal. Assuming symmetry, the total
volume unseen by the pathological inspection in the case




½I½fc þ c þð j   1Þðc þ dÞ; fc þ jðc þ dÞ m 
þI½fc þ c þð j   1Þðc þ dÞþm; fc þ jðc þ dÞ  
ð4Þ
The probability of detection can now be calculated using
Eq. 2.
The case of waste
In the case that the pathological process involves waste, the
probability of detection is affected through a larger total
volume covered by the inspection (the advancement effect)
and a possibly unseen part of wasted tissue (the pure waste
effect). Relaxing the assumption of symmetric tissue halves
and recalling that wL and wU refer to the wasted heights
from the lower and upper tissue halves, respectively, the
total inspected volume before correction becomes:
VPI ¼ I½ ðwL þ fc þ c þð nL   1Þðc þ dÞþmÞ;
0 þI½0; wU þ fc þ c þð nU   1Þðc þ dÞþm 
ð5Þ
with nL and nU the possibly different numbers of cuts
from the lower and upper tissue halves, respectively.
The total tissue volume covered by the inspection is
larger than that in the case of no waste, which
positively affects the probability of detection. However,
the occurrence of pathological waste implies that
metastases in the wasted tissue might go undetected.
Again, two situations may be discerned: large metasta-
ses with a size greater than the total height of the
wasted material (m≥w=wL+wU) and small metastases
(m<w). In the former case, m ≥ w, the metastasis will
always intersect with the first cut on either half. Conse-
quently, the wasting has no adverse effects on the
detection of the metastases, and no waste correction is
needed (UW=0). In the latter case, m<w, some metastases
m a yb em i s s e dw h e nt h e yf a l li nb e t w e e nt h ef i r s tc u t s
on both tissue halves without intersecting them. In line
with the unobserved parts of the inter-cut spaces, we
approximate the unobserved part of the wasted tissue
by:
UW ¼ I½ wL þ m;wU þI½ wL;wU   m  ðÞ =2 ð6Þ
Again, this could be approximated by I(−wL+m/2;
wU–m/2), leading to a marginally different outcome.
Furthermore, the unobserved parts of the inter-cut spaces
due to small metastases (m<d)s i m p l yg e n e r a l i s ef r o mE q .
4. Taking into account the waste (wL and wU), possibly
different numbers of cuts on the upper and lower halves
(nL and nU), and not imposing symmetry, the unseen





I½ ðwL þ fc þ c þð j   1Þðc þ dÞ ½ ;  ðwL þ fc þ jðc þ dÞ mÞ þ




I½wU þ fc þ c þð j   1Þðc þ dÞ; ½ wU þ fc þ jðc þ dÞ m þ
þI½wU þ fc þ c þð j   1Þðc þ dÞþm; wU þ fc þ c þ jðc þ dÞ  =2
Um<d ¼ Um<d;L þ Um<d;U
ð7Þ
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spaces, the probability of detection is determined using Eq. 2.
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